THE FUTURE OF NON-INVASIVE RESPIRATORY MONITORING
No tubes. No wires.
Non-invasively monitors patient’s breathing, gives reliable alerts for deteriorating volumes, apnea and obstructive breathing
Monitors breathing at a fraction of the cost of existing monitoring technologies by utilizing off-the-shelf hardware.
Intuitive & Simple
Straight-forward to use and interpret by all medical staff. Output consists of standard respiratory parameters.
BreatheVision was founded in 2013 on the need to develop a simple method for early detection of breathing deterioration in patients under conscious sedation... The founders built on their expertise in machine vision and missile navigation algorithms to invent a way to quantify breathing through analyzing chest micro-movements based on low-cost off the shelf hardware.
To improve patient safety by monitoring essential breathing parameters through machine learning technology and providing immediate warning.
Our first product, the SafeSed monitoring system, was developed for medical staff to continuously monitor respiration for post anesthesia sedated patients.
PROSPECTIVE TARGET MARKETS
COVID-19 respiratory monitoring
Remote and home monitoring
BreatheVision performed clinical validation of the SafeSed monitoring system at Meir Medical Center (Kfar Saba, Israel) and Tel-Aviv Medical Center.
The SafeSed system was compared to conventional means of respiratory monitoring:
Colonoscopy - SafeSed vs. Capnography
Operation Room - SafeSed vs. Anesthesia Machine
Healthy Volunteers - SafeSed vs. Spirometry
PACU post anesthesia - SafeSed vs. Pulse Oximetry and Clinical Logs
SafeSed signal vs. Capnograph signal
Clinical Project Manager
Menashe Terem, MA
CEO & Co-Founder
Former executive at El-Al Airlines who also led several medical device companies into OTC and professional markets worldwide.
Ditza Auerbach, PhD
Physicist experienced in leading imaging and machine learning R&D at Aspect Imaging and Applied Materials.
Prof. Ilan Shimshoni
Professor of Information Systems at the Computer Science Department at Technion, University of Haifa (Israel)
Adverse events associated with sedation
“Drug-induced respiratory depression is the primary cause of morbidity associated with sedation and analgesia”
American Society of Gastroenterology Nurses and Associates 2016
"…hospitals are expected to address monitoring for …respiratory
depression related to opioids for post-operative patients…. monitoring of ventilation may warrant … to assess breathing"
Centers for Medicare & Medicaid Services (CMS), 2014
Current monitoring methods
“Staff should … not to rely on pulse oximetry alone because pulse oximetry can suggest adequate oxygen saturation in patients … experiencing respiratory depression, especially when supplemental oxygen is being used.”
The Joint Commission Sentinel Event Alert, 2012
“Capnography devices often indicate problems where none exist… At worst, frequent alarm errors may lead to alarm fatigue and a tendency to ignore valid alarms.”
American Society for Gastrointestinal Endoscopy, 2012
“No studies have been published on the effectiveness of capnography on clinically important outcomes (rescue team activation, ICU transfers, or mortality). Etco2 may not accurately reflect the Paco2 in nonintubated patients in the setting of low-tidal volume breathing or mouth breathing... Capnography may require extra training of staff members before implementation.”
Anesthesia & Analgesia; Vol. 125 Issue 6, 2017
Future monitoring methods
“Quantitative monitoring of the volume of expired gas is strongly encouraged.”